Red List

AGLagilon health, inc.

Healthcare · Medical Care Facilities · small-cap ($1.6B)
-30.3%
from rolling 252-day high of $133.04 set 2026-07-17 · 34d ago
Current
$92.73
Decline depth
-30.3%
Decline σ
2.9σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$AGL landed on the list 2026-04-16, down 78.6% from its 52-week high that day — now down -30.3%.

It has clawed back 45.6 percentage points off that level. It bottomed 83.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-04-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

AGL qualifies for the Red List on decline depth.

Decline depth
-30.3%
From rolling 252-day high of $133.04, 34d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
2.9σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (7.21% per day).

The structural read

What price action says about AGL.

AGL qualifies for the Red List on decline depth — down -30.3% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: also showing 3/5 bearish time frames.

Earnings on file: 2026-08-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about AGL

What people ask.

Why is AGL on Broken Stocks?

AGL qualifies for the Red List on decline depth. It is down -30.3% from its rolling 252-day high of $133.04, set on 2026-07-17 — 34d ago.

Is AGL a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. AGL is down -30.3% from its 52-week high of $133.04, set 34d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is AGL a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is AGL trading inside its 52-week range?

At $92.73, AGL sits 67.9% of the way from its 52-week low ($7.48) to its 52-week high ($133.04). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has AGL been declining?

The current 30.3% decline accrued over 34d, which annualizes to roughly -325.3% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does AGL compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — AGL's decline is shallower than the sector median.

Does AGL's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.